Heart transplantation with ABO-identical versus ABO-compatible cardiac grafts: Influence on long-term survival

Scandinavian Cardiovascular Journal

Volumn 44, Issue 6, 2010, Pages 373-379

  Sjögren, Johan ^a   Ljungdahl Waller, Fredrik ^a   Senneby, Erik ^a   Ekmehag, Björn ^a   Koul, Bansi ^a   Nilsson, Johan ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Blood; Heart; Outcomes; Risk analysis modeling; Statistics; Survival analysis; Transplantation

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; GLUCOCORTICOID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; BLOOD COMPATIBILITY; BLOOD GROUP AB; BLOOD GROUP ABO SYSTEM; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GRAFT REJECTION; HEART GRAFT; HEART MUSCLE ISCHEMIA; HEART TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; SURVIVAL TIME;

ABO BLOOD-GROUP SYSTEM; ADULT; CYCLOSPORINE; FEMALE; GLUCOCORTICOIDS; GRAFT SURVIVAL; HEART FAILURE; HEART TRANSPLANTATION; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MODELS, STATISTICAL; PROSPECTIVE STUDIES; RISK ASSESSMENT; SWEDEN;

EID: 78649238700     PISSN: 14017431     EISSN: 16512006     Source Type: Journal    
DOI: 10.3109/14017431.2010.509450     Document Type: Article

References (22)

1. Taylor DO, Edwards LB, Aurora P, Christie JD, Dobbels F, Kirk R, et al. Registry of the International Society for Heart and Lung Transplantation: Twenty-fifth official adult heart transplant report-2008. J Heart Lung Transplant. 2008;27:943-56.
2. Taylor DO, Edwards LB, Boucek MM, Trulock EP, Aurora P, Christie J, et al. Registry of the International Society for Heart and Lung Transplantation: Twenty-fourth official adult heart transplant report-2007. J Heart Lung Transplant. 2007;26:769-81.
3. Parham P. The immune system. New York: Garland Publishing;2000.
4. Boucek MM, Aurora P, Edwards LB, Taylor DO, Trulock EP, Christie J, et al. Registry of the International Society for Heart and Lung Transplantation: Tenth official pediatric heart transplantation report-2007. J Heart Lung Transplant. 2007;26:796-807.
5. Kocher AA, Schlechta B, Ehrlich M, Ploner M, Khazen C, Schuster MP, et al. Effect of ABO blood type matching in cardiac transplant recipients. Transplant Proc. 2001;33:2752-4.
6. Neves C, Prieto D, Sola E, Antunes MJ. Heart transplantation from donors of different ABO blood type. Transplant Proc. 2009;41:938-40.
7. McKenzie FN, Tadros N, Stiller C, Keown P, Sinclair N, Kostuk W. Influence of donor-recipient lymphocyte crossmatch and ABO status on rejection risk in cardiac transplantation. Transplant Proc. 1987;19:3439-41.
8. Nakatani T, Aida H, Frazier OH, Macris MP. Effect of ABO blood type on survival of heart transplant patients treated with cyclosporine. J Heart Transplant. 1989;8:27-33.
9. Albat B, Missov E, Serre I, Baldet P, Chaptal PA. Short-term development of transplant-related coronary artery disease in orthotopic cardiac allograft recipients. Minerva Cardioangiol. 1995;43:435-8.
10. Schemper M, Heinze G. Probability imputation revisited for prognostic factor studies. Stat Med. 1997;16:73-80.
11. Katz M. Multivariable analysis: A practical guide for clinicians. Cambridge: Cambridge University Press; 1999.
12. Schoenfeld DA. Sample-size formula for the proportionalhazards regression model. Biometrics. 1983;39:499-503.
13. Tjang YS, van der Heijden GJ, Tenderich G, Grobbee DE, Korfer R. Survival analysis in heart transplantation: Results from an analysis of 1290 cases in a single center. Eur J Cardiothorac Surg. 2008;33:856-61.
14. Roussel JC, Baron O, Perigaud C, Bizouarn P, Pattier S, Habash O, et al. Outcome of heart transplants 15 to 20 years ago: Graft survival, post-transplant morbidity, and risk factors for mortality. J Heart Lung Transplant. 2008;27:486-93.
15. Costanzo-Nordin MR. Cardiac allograft vasculopathy: Relationship with acute cellular rejection and histocompatibility. J Heart Lung Transplant. 1992;11:S90-103.
16. Kubrich M, Petrakopoulou P, Kofler S, Nickel T, Kaczmarek I, Meiser BM, et al. Impact of coronary endothelial dysfunction on adverse long-term outcome after heart transplantation. Transplantation. 2008;85:1580-7.
17. Wahlers T, Fieguth HG, Jurmann M, Albes J, Hausen B, Demertzis S, et al. Graft coronary vasculopathy in cardiac transplantation-evaluation of risk factors by multivariate analysis. Eur J Cardiothorac Surg. 1996;10:1-5.
18. Mercer P, Sharples L, Edmunds J, Gittins R, Baines J, Wallwork J, et al. Evaluating the donor pool: Impact of using hearts from donors over the age of 49 years. Transplant Proc. 1997;29:3293-6.
19. Del Rizzo DF, Menkis AH, Pflugfelder PW, Novick RJ, McKenzie FN, Boyd WD, et al. The role of donor age and ischemic time on survival following orthotopic heart transplantation. J Heart Lung Transplant. 1999;18:310-9.
20. Borkon AM, Muehlebach GF, Jones PG, Bresnahan DR, Jr., Genton RE, Gorton ME, et al. An analysis of the effect of age on survival after heart transplant. J Heart Lung Transplant. 1999;18:668-74.
21. Aguero J, Almenar L, Martinez-Dolz L, Chamorro C, Moro J, Rueda J, et al. Influence of immunosuppression regimen on heart transplantation survival. Transplant Proc. 2006;38:2550-2.
22. Rexius H, Nilsson F, Jeppsson A. On the allocation of cardiac allografts from blood group-O donors. Scand Cardiovasc J. 2002;36:342-4.